Astrana Health, Inc. (ASTH)
ASTH Stock Price Chart
Explore Astrana Health, Inc. interactive price chart. Choose custom timeframes to analyze ASTH price movements and trends.
ASTH Company Profile
Discover essential business fundamentals and corporate details for Astrana Health, Inc. (ASTH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Care Facilities
IPO Date
11 Mar 2009
Employees
1.90k
Website
https://www.astranahealth.comCEO
Brandon K. Sim
Description
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
ASTH Financial Timeline
Browse a chronological timeline of Astrana Health, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is $0.33, while revenue estimate is $985.72m.
Earnings released on 7 May 2026
EPS came in at $0.30 surpassing the estimated $0.29 by +3.45%, while revenue for the quarter reached $965.10m , beating expectations by +1.67%.
Earnings released on 2 Mar 2026
EPS came in at $0.54 surpassing the estimated $0.15 by +260.00%, while revenue for the quarter reached $950.53m , beating expectations by +2.16%.
Earnings released on 6 Nov 2025
EPS came in at $0.01 falling short of the estimated $0.47 by -97.87%, while revenue for the quarter reached $956.05m , beating expectations by +2.75%.
Earnings released on 7 Aug 2025
EPS came in at $0.19 falling short of the estimated $0.36 by -47.22%, while revenue for the quarter reached $654.81m , missing expectations by -30.62%.
Earnings released on 8 May 2025
EPS came in at $0.14 falling short of the estimated $0.23 by -39.13%, while revenue for the quarter reached $620.39m , missing expectations by -1.63%.
Earnings released on 27 Feb 2025
EPS came in at -$0.15 falling short of the estimated $0.22 by -168.18%, while revenue for the quarter reached $665.21m , beating expectations by +7.77%.
Earnings released on 7 Nov 2024
EPS came in at $0.33 surpassing the estimated $0.32 by +3.13%, while revenue for the quarter reached $478.71m , missing expectations by -21.91%.
Earnings released on 7 Aug 2024
EPS came in at $0.40 surpassing the estimated $0.39 by +2.56%, while revenue for the quarter reached $486.27m , beating expectations by +10.33%.
Earnings released on 7 May 2024
EPS came in at $0.31 surpassing the estimated $0.30 by +3.33%, while revenue for the quarter reached $404.36m , missing expectations by -2.29%.
Earnings released on 27 Feb 2024
EPS came in at $0.26 surpassing the estimated $0.15 by +73.33%, while revenue for the quarter reached $353.04m , beating expectations by +3.48%.
Earnings released on 7 Nov 2023
EPS came in at $0.47 surpassing the estimated $0.27 by +74.07%, while revenue for the quarter reached $348.17m , missing expectations by -0.38%.
Earnings released on 7 Aug 2023
EPS came in at $0.28 surpassing the estimated $0.25 by +12.40%, while revenue for the quarter reached $348.21m , beating expectations by +1.82%.
Earnings released on 8 May 2023
EPS came in at $0.31 surpassing the estimated $0.31 by +1.08%, while revenue for the quarter reached $337.24m , beating expectations by +6.03%.
Earnings released on 23 Feb 2023
EPS came in at -$0.06 surpassing the estimated -$0.07 by +14.29%, while revenue for the quarter reached $294.21m , beating expectations by +18.94%.
Earnings released on 3 Nov 2022
EPS came in at $0.56 surpassing the estimated $0.32 by +75.82%, while revenue for the quarter reached $317.00m , beating expectations by +17.58%.
Earnings released on 4 Aug 2022
EPS came in at $0.25 surpassing the estimated $0.20 by +23.15%, while revenue for the quarter reached $269.70m , beating expectations by +10.64%.
Earnings released on 5 May 2022
EPS came in at $0.31 falling short of the estimated $0.32 by -3.13%, while revenue for the quarter reached $263.26m , beating expectations by +16.86%.
ASTH Stock Performance
Access detailed ASTH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
